Germany’s life sciences have more strength than the headlines show. At the Technical University of Berlin, an AI-supported biolab plans, runs and analyses experiments with a high degree of automation. German life sciences research can compete internationally; the substance, precision and people are there. It simply happens more quietly than the market notices.
Esteve proves the European version of this. No loud funding round, but a disciplined strategy: specialty pharma plus CDMO, targeted acquisitions, expansion into the US. Growth comes from clear strategic choices, strong execution and the right people, not only from capital. Leadership and human resources are what turn good ideas into results. Germany and Europe should talk more about what already works.
